NGENLA

Indicated For

pediatric growth hormone deficiency

About This Medication

# Pfizer RxPathways Patient Guide: How to Get NGENLA (somatrogon-ghla) at Low or No Cost NGENLA (somatrogon-ghla) is a once-weekly injection prescribed for pediatric patients aged 3 years and older with growth failure due to inadequate secretion of endogenous growth hormone. Pfizer RxPathways offers free or low-cost access to NGENLA for eligible uninsured or underinsured patients through its Patient Assistance Program (PAP).[1][6][7] ## About NGENLA **NGENLA** is a human growth hormone analog that helps children grow who aren't producing enough growth hormone on their own. Unlike daily growth hormone injections, NGENLA is given just once a week subcutaneously in the abdomen, thighs, buttocks, or upper arms. The dose is 0.66 mg/kg of body weight, and injection sites should be rotated weekly. Always inspect the solution for particles or discoloration before use, and follow the step-by-step instructions: wash hands, insert needle straight into skin, press button while counting to 10, then remove.[7][8][9] NGENLA treatment should be supervised by a healthcare provider experienced in managing pediatric growth hormone deficiency. Common supports include device training by nurses through the Pfizer Bridge Program, which coordinates insurance navigation, copay help, and shipments.[2][5] ## Who Qualifies for Pfizer RxPathways? Pfizer RxPathways is primarily for **uninsured or underinsured patients** who cannot afford their medications. It targets those without insurance coverage or with insufficient coverage, excluding government insurance like Medicare for copay assistance. The program provides NGENLA at no cost for eligible patients meeting income and other criteria.[1][2][4] Eligibility often requires applying to other funding sources first and providing denial proof if no assistance is found. All FDA-approved diagnoses for NGENLA qualify.[4][6] ## Income Eligibility Breakdown Specific income thresholds are not publicly listed and vary; eligibility details are determined through the Pfizer RxPathways Program Finder. Generally, it's based on household income, size, state, and federal poverty level (FPL), often up to 400-500% FPL for free medication, but confirm via application.[1][4] | Household Size | Estimated Max Income (300% FPL example)* | Notes | |---------------|---------------------------------------|-------| | 1 person | ~$45,180 | *Examples only; actual thresholds via Program Finder[1][4] | | 2 people | ~$61,320 | Primarily uninsured/underinsured[1] | | 3 people | ~$77,460 | Proof of income required | | 4 people | ~$93,600 | Excludes government insurance for copay[2] | *These are illustrative based on 2026 FPL estimates; use the online tool for precise eligibility. Patients must reside in the US.[1][4] ## Insurance Requirements Eligible patients typically have **no insurance or insufficient coverage**. The program excludes those with government insurance (e.g., Medicare, Medicaid) from copay assistance. Commercially insured patients may access copay help via Pfizer Bridge Program, but free drug PAP is for uninsured/underinsured. Exhaust other resources first and provide denial letters.[2][4][5] ## Step-by-Step Application Process 1. **Visit Pfizer RxPathways**: Go to www.PfizerRxPathways.com and use the Program Finder. Enter NGENLA, diagnosis, insurance type, income, household size, and state.[1][3][4] 2. **Choose Application Method**: Options include online via Pfizer PAP Connect (for prescribers/patients), phone at (800) 505-4426, or manual forms. For NGENLA, select product and diagnosis.[1][3][10] 3. **Gather Documents**: Prepare **proof of residency** (e.g., utility bill), **proof of income** (tax returns, pay stubs), and a valid **prescription** from your doctor. Upload digitally if online.[1][4] 4. **Enroll in Pfizer Bridge Program (Optional but Recommended)**: Doctor submits enrollment form via fax (1-800-479-2562) or HCP portal. Sign consents online if needed. Get copay/device support.[2][5] 5. **Submit and Track**: Prescriber or patient completes via PAP Connect or phone. Office staff can assist. Expect notification in 2-3 weeks.[1][3] 6. **Reauthorization**: Required periodically; resubmit updated documents.[provided] ## Timeline and Delivery Processing takes **2-3 weeks** for enrollment decision. Once approved, medication is **shipped to the patient via specialty pharmacy**. Pfizer Bridge Program arranges first shipment and handles delays. You'll get a welcome call within 1 business day of Bridge enrollment from 1-800-645-1280.[2][3][5][provided] ## Alternatives if Denied - **Appeal**: If insurance denies prior authorization, Pfizer Bridge helps with appeals.[5] - **Other Resources**: Re-run Program Finder for copay cards, state programs, or foundations. Provide denial docs for Pfizer PAP reconsideration.[4] - **Patient Access Network (PAN) Foundation** or similar for growth hormone support (check eligibility separately). - **Discuss with Doctor**: Switch to other growth hormones if appropriate; no biosimilars listed for NGENLA.[provided] ## Disclaimer This guide is for informational purposes only and not a substitute for professional medical or financial advice. Eligibility, terms, and availability can change; always verify with Pfizer RxPathways at (800) 505-4426 or www.PfizerRxPathways.com. Pfizer does not guarantee approval. Consult your healthcare provider for treatment decisions. Data current as of program details provided; revised 2024.[1][2][provided]

Program information last verified: March 30, 2026